Mathematical modeling studies based on data from sub-Saharan African countries have suggested that substantial declines in tuberculosis incidence could be achieved by initiating antiretroviral therapy as soon as HIV infection is known, without waiting for a threshold CD4 count to be reached [21], [22]. This evidence concerns the gene CD4 and tuberculosis.